Clincosm LogoSign in Get a demo

Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT00845390
Collaborator
(none)
100
Enrollment
1
Location
8
Duration (Months)
12.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study will be a qualitative survey to understand the expectations of defibrillator patients with regards to their device. It is unknown what ICD (implantable-cardioverter defibrillator) patients understand about their device and its purpose, thus we will be talking to them about their device. Also, we will be interested in studying their beliefs on how the ICD impacts their life expectancy and quality of life.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Other
    Official Title:
    Patient Expectations After ICD Implantation
    Study Start Date :
    Dec 1, 2008
    Actual Primary Completion Date :
    Aug 1, 2009
    Actual Study Completion Date :
    Aug 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    ICD Patients

    ICD patients

    Outcome Measures

    Primary Outcome Measures

    1. Why did you have an ICD implanted? [after ICD implantation]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients are eligible for inclusion. We hope to acquire a wide range of ages but are not limited to a specific set.
    Exclusion Criteria:
    • Non-English speakers will be excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UCSF Arrhythmia and Device Clinic San Francisco California United States 94143

    Sponsors and Collaborators

    • University of California, San Francisco

    Investigators

    • Principal Investigator: Rita F Redberg, M.D., University of California, San Francisco

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of California, San Francisco
    ClinicalTrials.gov Identifier:
    NCT00845390
    Other Study ID Numbers:
    • CHR #08033561
    First Posted:
    Feb 18, 2009
    Last Update Posted:
    Mar 21, 2022
    Last Verified:
    Mar 1, 2022

    Study Results

    No Results Posted as of Mar 21, 2022